Literature DB >> 18045879

Polyglutamylation is a post-translational modification with a broad range of substrates.

Juliette van Dijk1, Julie Miro, Jean-Marc Strub, Benjamin Lacroix, Alain van Dorsselaer, Bernard Edde, Carsten Janke.   

Abstract

Polyglutamylation is a post-translational modification that generates lateral acidic side chains on proteins by sequential addition of glutamate amino acids. This modification was first discovered on tubulins, and it is important for several microtubule functions. Besides tubulins, only the nucleosome assembly proteins NAP1 and NAP2 have been shown to be polyglutamylated. Here, using a proteomic approach, we identify a large number of putative substrates for polyglutamylation in HeLa cells. By analyzing a selection of these putative substrates, we show that several of them can serve as in vitro substrates for two of the recently discovered polyglutamylases, TTLL4 and TTLL5. We further show that TTLL4 is the main polyglutamylase enzyme present in HeLa cells and that new substrates of polyglutamylation are indeed modified by TTLL4 in a cellular context. No clear consensus polyglutamylation site could be defined from the primary sequence of the here-identified new substrates of polyglutamylation. However, we demonstrate that glutamate-rich stretches are important for a protein to become polyglutamylated. Most of the newly identified substrates of polyglutamylation are nucleocytoplasmic shuttling proteins, including many chromatin-binding proteins. Our work reveals that polyglutamylation is a much more widespread post-translational modification than initially thought and thus that it might be a regulator of many cellular processes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045879     DOI: 10.1074/jbc.M705813200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

Review 1.  Polyglutamylation: a fine-regulator of protein function? 'Protein Modifications: beyond the usual suspects' review series.

Authors:  Carsten Janke; Krzysztof Rogowski; Juliette van Dijk
Journal:  EMBO Rep       Date:  2008-06-20       Impact factor: 8.807

2.  Loss of RPGR glutamylation underlies the pathogenic mechanism of retinal dystrophy caused by TTLL5 mutations.

Authors:  Xun Sun; James H Park; Jessica Gumerson; Zhijian Wu; Anand Swaroop; Haohua Qian; Antonina Roll-Mecak; Tiansen Li
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

3.  Molecular interactions between tubulin tails and glutamylases reveal determinants of glutamylation patterns.

Authors:  Kathiresan Natarajan; Sudarshan Gadadhar; Judith Souphron; Maria M Magiera; Carsten Janke
Journal:  EMBO Rep       Date:  2017-05-08       Impact factor: 8.807

Review 4.  Fly Fishing for Histones: Catch and Release by Histone Chaperone Intrinsically Disordered Regions and Acidic Stretches.

Authors:  Christopher Warren; David Shechter
Journal:  J Mol Biol       Date:  2017-06-10       Impact factor: 5.469

5.  More is not always better: hyperglutamylation leads to neurodegeneration.

Authors:  Anna Akhmanova; Casper C Hoogenraad
Journal:  EMBO J       Date:  2018-11-23       Impact factor: 11.598

Review 6.  The chemical complexity of cellular microtubules: tubulin post-translational modification enzymes and their roles in tuning microtubule functions.

Authors:  Christopher P Garnham; Antonina Roll-Mecak
Journal:  Cytoskeleton (Hoboken)       Date:  2012-04-26

7.  Botch is a γ-glutamyl cyclotransferase that deglycinates and antagonizes Notch.

Authors:  Zhikai Chi; Sean T Byrne; Andrew Dolinko; Maged M Harraz; Min-Sik Kim; George Umanah; Jun Zhong; Rong Chen; Jianmin Zhang; Jinchong Xu; Li Chen; Akhilesh Pandey; Ted M Dawson; Valina L Dawson
Journal:  Cell Rep       Date:  2014-04-24       Impact factor: 9.423

8.  Biallelic variants in TTLL5, encoding a tubulin glutamylase, cause retinal dystrophy.

Authors:  Panagiotis I Sergouniotis; Christina Chakarova; Cian Murphy; Mirjana Becker; Eva Lenassi; Gavin Arno; Monkol Lek; Daniel G MacArthur; Shomi S Bhattacharya; Anthony T Moore; Graham E Holder; Anthony G Robson; Uwe Wolfrum; Andrew R Webster; Vincent Plagnol
Journal:  Am J Hum Genet       Date:  2014-05-01       Impact factor: 11.025

9.  Increased levels of a unique post-translationally modified betaIVb-tubulin isotype in liver cancer.

Authors:  Leah M Miller; Anuradha Menthena; Champak Chatterjee; Pascal Verdier-Pinard; Phyllis M Novikoff; Susan Band Horwitz; Ruth Hogue Angeletti
Journal:  Biochemistry       Date:  2008-06-21       Impact factor: 3.162

10.  TTLL10 is a protein polyglycylase that can modify nucleosome assembly protein 1.

Authors:  Koji Ikegami; Daisuke Horigome; Masahiro Mukai; Itamar Livnat; Grant R MacGregor; Mitsutoshi Setou
Journal:  FEBS Lett       Date:  2008-03-10       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.